Abstract
In 1962, in the wake of the thalidomide crisis, a new Amendment to the Food and Drugs Act introduced Randomized Controlled Trials (RCTs) into the regulations governing the licensing of medicines. It was believed that requiring companies to demonstrate their products were effective through RCTs would contribute to safety. In 1962, RCTs were a little-understood technique. It was thought trials would produce generalizable knowledge with similar outcomes for successive trials. As a result, regulators adopted a criterion of two positive placebo-controlled trials for licensing medicine. For physicians keen to stall therapeutic bandwagons and eliminate ineffective treatments, a negative RCT result was a good outcome. When made a gateway to the market, companies, in contrast, had an interest to transform RCTs from assessments that might throw up unexpected or negative results into Randomized Controlled Assays (RCAs) that efficiently generated approvable results. This article outlines the differences between RCTs and RCAs, the steps companies took to transform RCTs into RCAs, and the consequences of this transformation.
Publisher
Springer Publishing Company
Subject
Psychiatry and Mental health,Clinical Psychology
Reference62 articles.
1. Ahmad, R. , Gordon, A. C. , Aylin, P. , Redhead, J. , Holmes, A. , & Evans, D. P . (2022). Effective knowledge mobilisation: Creating environments for quick generation, dissemination, and use of evidence. BMJ (Clinical Research Ed.) , 379, e070195. https://doi.org/10.1136/bmj-2022-070195
2. Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
3. Beaumont, G . (1996). The place of clomipramine in psychopharmacology. In Healy D. (Ed.), The psychopharmacologists, volume 1 (pp. 309–328). London: Chapman & Hall.
4. Measurement and organization in psychopharmacology,1998
5. The university group diabetes program 1961–1978, pioneering randomized controlled trial;International Journal of Epidemiology,2017